HIGHLIGHTS
- Who: R-P and collaborators from the Henan University have published the research work: Dual-responsive smart nano-platform targeting peptide modifications synergistically enhances multimodal therapy for liver cancer, in the Journal: (JOURNAL)
- How: In this study the following equipment were used for different experiments. The results showed that HMCD9P NPs have excellent photothermal properties and could be used for anti-tumor photothermal therapy. The results indicated that the HMCD9P nano-drugs could break their amide bonds in a microacidic environment and then open the pores of the hollow mesoporous material to release the drug . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.